STARPAX BIOPHARMA

Starpax is a dual Biopharma / Medtech Company that has developed a revolutionary platform for treating cancer... The Starpax Technology is not yet approved for commercial use. Clinical trials are planned to begin in 2024... ‘' To overcome all these challenges, it is necessary to go beyond the frontiers of knowledge, … It takes imagination. Then Starpax offers a never seen technology to enter into a new era of cancer treatment.''

Also known as: Starpax, Starpax Biopharma Inc.